Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Total glucosides of paeony for prevention of gout flares during urate-lowering therapy
ChiCTR2000038289Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- Oct 2020
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of total glucosides of paeony and febuxostat in gout (4 arms), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoints: Frequency of gout flare and Adverse events. Started Oct 2020; status: recruiting.
02
Drugs
total glucosides of paeonyfebuxostat
03
Conditions
gout
Beyond the preview
Go deeper on ChiCTR2000038289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038289.